Filter, blood, cardiopulmonary bypass

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

现在购买

下载 公众评估报告 (PAR)
17-11-2017

可用日期:

LivaNova Australia Pty Ltd

类:

Class I

厂商:

Medtronic Inc Cardiac Rhythm Disease Management , 7000 Central Avenue NE, Minneapolis, Minnesota, 55432 United States Of America

治疗领域:

33309 - Filter, blood, cardiopulmonary bypass

疗效迹象:

Filter particle or blood clots flowing into the blood stream during cardiopulmonary bypass

授权状态:

A

授权日期:

2007-09-28

搜索与此产品相关的警报